These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11835079)

  • 1. Population Pharmacokinetics of Digoxin in Duchenne Muscular Dystrophy (DMD) Patients.
    Tateishi M; Ebihara A
    Am J Ther; 1994 Aug; 1(2):144-149. PubMed ID: 11835079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
    Yukawa E; Mine H; Higuchi S; Aoyama T
    J Pharm Pharmacol; 1992 Sep; 44(9):761-5. PubMed ID: 1360530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
    Yukawa E; Nomiyama N; Higuchi S; Aoyama T
    Ther Drug Monit; 1993 Apr; 15(2):75-82. PubMed ID: 8503142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis.
    Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y
    Eur J Clin Pharmacol; 2001 Apr; 57(1):19-24. PubMed ID: 11372585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.
    Yukawa E; Honda T; Ohdo S; Higuchi S; Aoyama T
    J Clin Pharmacol; 1997 Feb; 37(2):92-100. PubMed ID: 9055134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic investigation of digoxin in Japanese neonates.
    Yukawa E; Akiyama K; Suematsu F; Yukawa M; Minemoto M
    J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenobarbitone population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
    Yukawa E; Higuchi S; Aoyama T
    J Pharm Pharmacol; 1992 Sep; 44(9):755-60. PubMed ID: 1360529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New and simple method for estimating metildigoxin dosing regimens by multiple trough screen analysis.
    Yukawa E
    Int J Clin Pharmacol Ther; 1995 Nov; 33(11):605-11. PubMed ID: 8688985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling.
    Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M
    Drugs Aging; 2011 Oct; 28(10):831-41. PubMed ID: 21970310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic investigation of digoxin in Japanese infants and young children.
    Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M
    J Clin Pharmacol; 2011 Jun; 51(6):857-63. PubMed ID: 20592416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population pharmacokinetic analysis of the influence of nutritional status of digoxin in hospitalized Korean patients.
    Choi SA; Yun HY; Lee ES; Shin WG
    Clin Ther; 2014 Mar; 36(3):389-400. PubMed ID: 24612944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of digoxin in pediatric patients.
    Martín-Suárez A; Falcao AC; Outeda M; Hernández FJ; González MC; Quero M; Arranz I; Lanao JM
    Ther Drug Monit; 2002 Dec; 24(6):742-5. PubMed ID: 12451291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of digoxin in Thai pediatric patients.
    Preechagoon Y; Somsaard P; Petcharattana S
    J Med Assoc Thai; 2009 Oct; 92(10):1324-35. PubMed ID: 19845241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some comments and suggestions concerning population pharmacokinetic modeling, especially of digoxin, and its relation to clinical therapy.
    Jelliffe RW
    Ther Drug Monit; 2012 Aug; 34(4):368-77. PubMed ID: 22735674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of platinum after nedaplatin administration and model validation in adult patients.
    Ishibashi T; Yano Y; Oguma T
    Br J Clin Pharmacol; 2003 Aug; 56(2):205-13. PubMed ID: 12895194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NONMEM population pharmacokinetic studies of cytosine arabinoside after high-dose and after loading bolus followed by continuous infusion of the drug in pediatric patients with leukemias.
    Periclou AP; Avramis VI
    Cancer Chemother Pharmacol; 1996; 39(1-2):42-50. PubMed ID: 8995498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive performance of serum digoxin concentration in patients with congestive heart failure by a hyperbolic model based on creatinine clearance.
    Konishi H; Shimizu S; Chiba M; Minouchi T; Koida M; Yamaji A
    J Clin Pharm Ther; 2002 Aug; 27(4):257-65. PubMed ID: 12174027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of digoxin in elderly patients.
    Chen R; Zou SL; Wang ML; Jiang Y; Xue H; Qian CY; Xia ZL
    Eur J Drug Metab Pharmacokinet; 2013 Jun; 38(2):115-21. PubMed ID: 23096939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.